147 related articles for article (PubMed ID: 28487383)
1. Monitoring Tumor Response to Antivascular Therapy Using Non-Contrast Intravoxel Incoherent Motion Diffusion-Weighted MRI.
Shi C; Liu D; Xiao Z; Zhang D; Liu G; Liu G; Chen H; Luo L
Cancer Res; 2017 Jul; 77(13):3491-3501. PubMed ID: 28487383
[TBL] [Abstract][Full Text] [Related]
2. Intravoxel incoherent motion diffusion-weighted imaging in head and neck squamous cell carcinoma: assessment of perfusion-related parameters compared to dynamic contrast-enhanced MRI.
Fujima N; Yoshida D; Sakashita T; Homma A; Tsukahara A; Tha KK; Kudo K; Shirato H
Magn Reson Imaging; 2014 Dec; 32(10):1206-13. PubMed ID: 25131628
[TBL] [Abstract][Full Text] [Related]
3. Intravoxel incoherent motion diffusion-weighted imaging for monitoring chemotherapeutic efficacy in gastric cancer.
Song XL; Kang HK; Jeong GW; Ahn KY; Jeong YY; Kang YJ; Cho HJ; Moon CM
World J Gastroenterol; 2016 Jun; 22(24):5520-31. PubMed ID: 27350730
[TBL] [Abstract][Full Text] [Related]
4. Intravoxel incoherent motion diffusion-weighted MR imaging for monitoring the therapeutic efficacy of the vascular disrupting agent CKD-516 in rabbit VX2 liver tumors.
Joo I; Lee JM; Han JK; Choi BI
Radiology; 2014 Aug; 272(2):417-26. PubMed ID: 24697148
[TBL] [Abstract][Full Text] [Related]
5. Relationship between intravoxel incoherent motion diffusion-weighted MRI and dynamic contrast-enhanced MRI in tissue perfusion of cervical cancers.
Lee EY; Hui ES; Chan KK; Tse KY; Kwong WK; Chang TY; Chan Q; Khong PL
J Magn Reson Imaging; 2015 Aug; 42(2):454-9. PubMed ID: 25413245
[TBL] [Abstract][Full Text] [Related]
6. Functional evaluation of therapeutic response of HCC827 lung cancer to bevacizumab and erlotinib targeted therapy using dynamic contrast-enhanced and diffusion-weighted MRI.
Chen YF; Yuan A; Cho KH; Lu YC; Kuo MY; Chen JH; Chang YC
PLoS One; 2017; 12(11):e0187824. PubMed ID: 29121075
[TBL] [Abstract][Full Text] [Related]
7. Relationship between diffusion parameters derived from intravoxel incoherent motion MRI and perfusion measured by dynamic contrast-enhanced MRI of soft tissue tumors.
Marzi S; Stefanetti L; Sperati F; Anelli V
NMR Biomed; 2016 Jan; 29(1):6-14. PubMed ID: 26602061
[TBL] [Abstract][Full Text] [Related]
8. Comparison of intravoxel incoherent motion diffusion-weighted MR imaging with dynamic contrast-enhanced MRI for differentiating lung cancer from benign solitary pulmonary lesions.
Yuan M; Zhang YD; Zhu C; Yu TF; Shi HB; Shi ZF; Li H; Wu JF
J Magn Reson Imaging; 2016 Mar; 43(3):669-79. PubMed ID: 26340144
[TBL] [Abstract][Full Text] [Related]
9. Performing IVIM-DWI using the multifunctional nanosystem for the evaluation of the antitumor microcirculation changes.
Gao P; Liu Y; Shi C; Liu Y; Luo L
MAGMA; 2020 Aug; 33(4):517-526. PubMed ID: 31897903
[TBL] [Abstract][Full Text] [Related]
10. [Study on the significance of intravoxel incoherent motion quantitative index combined with time-signal intensity curve in the early diagnosis of residual lesions in non-small cell lung cancer after argon-helium cryosurgery].
Zong DW; Guo CY; Li HL; Cheng HT; Hu HT; Xiao JC
Zhonghua Zhong Liu Za Zhi; 2018 Nov; 40(11):851-856. PubMed ID: 30481938
[No Abstract] [Full Text] [Related]
11. Chemotherapy response evaluation in a mouse model of gastric cancer using intravoxel incoherent motion diffusion-weighted MRI and histopathology.
Cheng J; Wang Y; Zhang CF; Wang H; Wu WZ; Pan F; Hong N; Deng J
World J Gastroenterol; 2017 Mar; 23(11):1990-2001. PubMed ID: 28373765
[TBL] [Abstract][Full Text] [Related]
12. Monitoring Vascular Disrupting Therapy in a Rabbit Liver Tumor Model: Relationship between Tumor Perfusion Parameters at IVIM Diffusion-weighted MR Imaging and Those at Dynamic Contrast-enhanced MR Imaging.
Joo I; Lee JM; Grimm R; Han JK; Choi BI
Radiology; 2016 Jan; 278(1):104-13. PubMed ID: 26200601
[TBL] [Abstract][Full Text] [Related]
13. The diagnostic efficiency of the perfusion-related parameters in assessing the vascular disrupting agent (CA4P) response in a rabbit VX2 liver tumor model.
Meng F; Zou B; Yang R; Duan Q; Qian T
Acta Radiol; 2022 Sep; 63(9):1147-1156. PubMed ID: 34279135
[TBL] [Abstract][Full Text] [Related]
14. Intravoxel Incoherent Motion Diffusion-Weighted Imaging for Predicting and Monitoring the Response of Anti-Angiogenic Treatment in the Orthotopic Nude Mouse Model of Lung Adenocarcinoma.
Wan Q; Bao Y; Xia X; Liu J; Wang P; Peng Y; Xie X; He J; Li X
J Magn Reson Imaging; 2022 Apr; 55(4):1202-1210. PubMed ID: 34570394
[TBL] [Abstract][Full Text] [Related]
15. Correlative assessment of tumor microcirculation using contrast-enhanced perfusion MRI and intravoxel incoherent motion diffusion-weighted MRI: is there a link between them?
Bisdas S; Braun C; Skardelly M; Schittenhelm J; Teo TH; Thng CH; Klose U; Koh TS
NMR Biomed; 2014 Oct; 27(10):1184-91. PubMed ID: 25088433
[TBL] [Abstract][Full Text] [Related]
16. Importance of Bevacizumab Maintenance Following Combination Chemotherapy in Human Non-small Cell Lung Cancer Xenograft Models.
Ishikura N; Yanagisawa M; Noguchi-Sasaki M; Iwai T; Yorozu K; Kurasawa M; Sugimoto M; Yamamoto K
Anticancer Res; 2017 Feb; 37(2):623-629. PubMed ID: 28179309
[TBL] [Abstract][Full Text] [Related]
17. Diffusion-Related MRI Parameters for Assessing Early Treatment Response of Liver Metastases to Cytotoxic Therapy in Colorectal Cancer.
Kim JH; Joo I; Kim TY; Han SW; Kim YJ; Lee JM; Han JK
AJR Am J Roentgenol; 2016 Sep; 207(3):W26-32. PubMed ID: 27303858
[TBL] [Abstract][Full Text] [Related]
18. Intravoxel Incoherent Motion Diffusion-Weighted Imaging Versus Dynamic Contrast-Enhanced Magnetic Resonance Imaging: Comparison of the Diagnostic Performance of Perfusion-Related Parameters in Breast.
Jiang L; Lu X; Hua B; Gao J; Zheng D; Zhou Y
J Comput Assist Tomogr; 2018; 42(1):6-11. PubMed ID: 28786902
[TBL] [Abstract][Full Text] [Related]
19. Dual inhibition of PFKFB3 and VEGF normalizes tumor vasculature, reduces lactate production, and improves chemotherapy in glioblastoma: insights from protein expression profiling and MRI.
Zhang J; Xue W; Xu K; Yi L; Guo Y; Xie T; Tong H; Zhou B; Wang S; Li Q; Liu H; Chen X; Fang J; Zhang W
Theranostics; 2020; 10(16):7245-7259. PubMed ID: 32641990
[No Abstract] [Full Text] [Related]
20. Low-molecular contrast agent dynamic contrast-enhanced (DCE)-MRI and diffusion-weighted (DW)-MRI in early assessment of bevacizumab treatment in breast cancer xenografts.
Moestue SA; Huuse EM; Lindholm EM; Bofin A; Engebraaten O; Mælandsmo GM; Akslen LA; Gribbestad IS
J Magn Reson Imaging; 2013 Nov; 38(5):1043-53. PubMed ID: 23908122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
